Medical Services International Inc. Completes Testing For European Union (EU) Application
Main Category: Liver Disease / HepatitisAlso Included In: Medical Devices / Diagnostics; Regulatory Affairs / Drug Approvals
Article Date: 12 Sep 2007 - 0:00 PDT
| Patient / Public: | ![]() |
4 (2 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that it has completed testing with its VScan HIV test kit and the VScan Hepatitis C test kit in Europe. Completion of this testing will allow it to apply for EU approval of both test kits.
EU approval would allow the Company to expand its distribution network with the initial setup of 10 distributors in Europe. It is anticipated that when EU approval is received that it will result in the sale of up to 1.0 million (gross sales of $2,000,000USD) test kits in the first year. It is believed based on studies completed that this will be a very active market with rapid growth potential. Once approval is received the Company expects to also market the kits through an independent internet site
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Malaria, Dengue Fever, West Nile, Syphilis and Prostate Cancer.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF".
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies
Medical Services International Inc.
http://www.medicalservicesintl.com
Visit our liver disease / hepatitis section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/82200.php>
APA
http://www.medicalnewstoday.com/releases/82200.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




